LeMaitre Vascular (LMAT) in Focus: Stock Rises 7.3% - Tale of the Tape

LeMaitre Vascular, Inc. LMAT was a big mover last session, with shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the volatile price range of $7.65 to $8.14 since April 7.

This medical devices and implants company has seen no estimate revisions in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

LeMaitre Vascular currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Better-ranked Medical Product stocks include Hospira Inc. HSP, Enzymotec Ltd. ENZY and Cardica Inc. CRDC. While Hospira and Enzymotec sport a Zacks Rank #1 (Strong Buy), Cardica carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

CARDICA INC CRDC: Free Stock Analysis Report

ENZYMOTEC LTD ENZY: Free Stock Analysis Report

HOSPIRA INC HSP: Free Stock Analysis Report

LEMAITRE VASCLR LMAT: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs